← Open Payments lookup

SARAH DAROUSE: Open Payments

NPI 1801380829 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,081 in 105 payments from 19 companies in 2025. Trend: 2023 $1,383 · 2024 $2,012 · 2025 $2,081

Food & beverage: $2,081
CompanyPaymentsAmount
GlaxoSmithKline, LLC.38$528
GENZYME CORPORATION14$431
AstraZeneca Pharmaceuticals LP13$274
Grifols USA, LLC4$104
Verona Pharma, Inc.4$83
Insmed, Inc.4$77
Actelion Pharmaceuticals US, Inc.3$77
REVANCE THERAPEUTICS, INC.2$76
Boehringer Ingelheim Pharmaceuticals, Inc.4$71
Merck Sharp & Dohme LLC3$61

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, FASENRA, Prolastin-C Liquid, Ohtuvayre, Arikayce, TEZSPIRE.

Industry payments across LA — which companies pay providers there.